CAMK2G and myocardial infarction: Similarly, cardiac CaMKII inhibition or targeted deletion of CaMKIIδ protects against adverse myocardial remodeling following myocardial infarction or TAB [37–39], presumably mediated in part by the loss of CaMKII suppression of KATP channel expression.